Century Therapeutics (IPSC) Interest Coverage Ratio (2020 - 2023)
Century Therapeutics (IPSC) reported Interest Coverage Ratio of 257.92 for Q2 2023, down 171.49% year-over-year from 360.8 in Q2 2022, and down 179.78% on a QoQ basis from 92.19 in Q1 2023.
Century Therapeutics (IPSC) has 4 years of Interest Coverage Ratio data on file, last reported at 257.92 in Q2 2023.
- Quarterly Interest Coverage Ratio fell 171.49% year-over-year to 257.92 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was 1071.87 (down 1249.05% YoY) and the FY2023 annual result came in at 271.38, down 189.97% from the prior year.
- Interest Coverage Ratio fell to 257.92 in Q2 2023 per IPSC's latest filing, from 92.19 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 45.41 in Q4 2020 and bottomed at 291.8 in Q3 2020.
- The 4-year median for Interest Coverage Ratio is 89.67 (2021), against an average of 113.15.
- The widest annual swing landed in 2021, when Interest Coverage Ratio jumped 72.51%; it then sank 171.49% in 2023.
- Tracing IPSC's Interest Coverage Ratio over 4 years: stood at 45.41 in 2020, then plunged by 91.9% to 87.14 in 2021, then jumped by 40.56% to 51.8 in 2022, then slumped by 397.93% to 257.92 in 2023.
- Per Business Quant, the three latest IPSC Interest Coverage Ratio figures stand at 257.92 (Q2 2023), 92.19 (Q1 2023), and 51.8 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Century Therapeutics | 474.01 Mn | 474.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -257.92 |
| Mar 31, 2023 | -92.19 |
| Dec 31, 2022 | -51.80 |
| Sep 30, 2022 | -107.22 |
| Jun 30, 2022 | -95.00 |
| Mar 31, 2022 | -119.22 |
| Dec 31, 2021 | -87.14 |
| Sep 30, 2021 | -80.21 |
| Jun 30, 2021 | -72.39 |
| Mar 31, 2021 | -57.52 |
| Dec 31, 2020 | -45.41 |
| Sep 30, 2020 | -291.80 |